Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Darren R Feldman Toni K Choueiri Eric J Small Michael J. Morris Susan Halabi |
| Publication date | November 14, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |